RBQM Updates for Clinical Experts

Aug 2020

Risk-based Monitoring Software Key Players Influencing the Market

By |2020-09-22T08:55:47+02:00August 26, 2020|News|Comments Off on Risk-based Monitoring Software Key Players Influencing the Market

The report provides key statistics on the market status of the leading Risk-based Monitoring (RBM) Software market players and offers key trends and opportunities in the market.

May 2020

AI-Enhanced Machine Learning Predictions for All Clinical Research Metrics

By |2024-05-10T17:02:08+02:00May 27, 2020|AI in Clinical Trials, Neat Features, News|Comments Off on AI-Enhanced Machine Learning Predictions for All Clinical Research Metrics

MyRBQM® Portal's new Machine Learning predictive analytics model is far less sensitive to noise, it better generalizes data, and provides narrower CIs in long time series. Singular Spectrum Analysis is particularly valuable for long time series, as mostly observed in clinical trials.

Mar 2020

Cyntegrity Amongst Companies Fighting Back the COVID-19 Outbreak

By |2020-03-23T13:48:08+02:00March 23, 2020|News|Comments Off on Cyntegrity Amongst Companies Fighting Back the COVID-19 Outbreak

Frontiers Health Ecosystem Companies Fighting Back the COVID-19 Outbreak As the COVID-19 outbreak continues, it has become even more challenging for patients to seek in- person medical care and for healthcare providers (HCP) to guarantee community health services for people who may have symptoms [...]

Mar 2020

Coronavirus | COVID-19 RACT Now Available

By |2022-07-21T12:15:31+02:00March 20, 2020|Neat Features, News, RBQM Product Updates|Comments Off on Coronavirus | COVID-19 RACT Now Available

Cyntegrity developed a special COVID-19 RACT that guides those involved in clinical trials on specific risks which may arise as a result of COVID-19, and how they can mitigate them. This special RACT is part of the COVID-19 rapid deployment pack for ad-hoc centralized monitoring.

Mar 2020

Coronavirus | What if you can no longer visit your sites?

By |2024-11-25T18:19:38+02:00March 6, 2020|Blog|Comments Off on Coronavirus | What if you can no longer visit your sites?

We can help establish near real-time centralized monitoring, enable the use of "ad-hoc crisis management" Key Risk Indicators (KRIs), and mitigate patient safety and study quality risks.

Mar 2020

Best Case Studies for RBQM | Merz Pharma’s RBQM Journey

By |2020-11-03T14:50:45+02:00March 5, 2020|Case Studies, News|Comments Off on Best Case Studies for RBQM | Merz Pharma’s RBQM Journey

This week Applied Clinical Trials published an interesting case study of the risk-based quality management learning curve. The provision of a set of training modules helped Merz Pharma to initiate a smooth RBQM rollout.

Feb 2020

Indication Focused RBQM for Rare Disease Drug Development

By |2020-02-28T08:30:17+02:00February 28, 2020|Blog|Comments Off on Indication Focused RBQM for Rare Disease Drug Development

Adaptive and intelligent Risk Based Quality Management (RBQM) is a powerful strategy for rare disease research. One of the main benefits is that RBQM allows for patient-centric trial design that is uniquely tailored to the specific rare disease.

Feb 2020

Healthy Volunteers – Phase 1 RACT Now Available

By |2024-07-31T15:50:55+02:00February 11, 2020|Neat Features, News, Phase 1 - FIH, RBQM Product Updates|Comments Off on Healthy Volunteers – Phase 1 RACT Now Available

The need for a controlled research environment adds another risk dimension to the Phase 1 study design. The new Healthy Volunteers - Phase 1 RACT serves as a helpful source to ensure maximum subject safety and a reliable outcome.

Go to Top